DE69833375D1 - Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung - Google Patents

Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Info

Publication number
DE69833375D1
DE69833375D1 DE69833375T DE69833375T DE69833375D1 DE 69833375 D1 DE69833375 D1 DE 69833375D1 DE 69833375 T DE69833375 T DE 69833375T DE 69833375 T DE69833375 T DE 69833375T DE 69833375 D1 DE69833375 D1 DE 69833375D1
Authority
DE
Germany
Prior art keywords
preparation
taxed
implants
release
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833375T
Other languages
English (en)
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Fromegadomegaric Heimgartner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debio Recherche Pharmaceutique SA
Original Assignee
Debio Recherche Pharmaceutique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Recherche Pharmaceutique SA filed Critical Debio Recherche Pharmaceutique SA
Application granted granted Critical
Publication of DE69833375D1 publication Critical patent/DE69833375D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
DE69833375T 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung Expired - Lifetime DE69833375D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04
PCT/EP1998/003270 WO1998055101A1 (fr) 1997-06-04 1998-06-02 Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication

Publications (1)

Publication Number Publication Date
DE69833375D1 true DE69833375D1 (de) 2006-04-13

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833375T Expired - Lifetime DE69833375D1 (de) 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Country Status (10)

Country Link
US (1) US6319512B1 (de)
EP (1) EP1001743B1 (de)
JP (1) JP2002511075A (de)
AT (1) ATE316779T1 (de)
AU (1) AU742372B2 (de)
CA (1) CA2291659A1 (de)
DE (1) DE69833375D1 (de)
IL (1) IL133105A (de)
NO (1) NO995908L (de)
WO (1) WO1998055101A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
CA2423431A1 (en) * 2000-10-06 2002-04-11 Durect Corporation Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
AU2002324447B2 (en) 2001-06-22 2006-06-29 Durect Corporation Zero-order prolonged release coaxial implants
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
DE10237572A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
EP2633853A1 (de) * 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Langzeitabgabe von Lieferungsformulierungen und Verwendungsverfahren dafür
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
KR101283946B1 (ko) * 2005-07-18 2013-07-15 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 약물 함유 임플란트 및 그의 사용 방법
KR20140133968A (ko) * 2005-12-22 2014-11-20 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
AU2007235232B2 (en) 2006-04-06 2013-07-11 Nupathe Inc. Implants for the treatment of dopamine associated states
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
WO2010088697A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Antimicrobial accessory for an implantable medical device
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
US20100278895A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
EP2477612A2 (de) * 2009-09-17 2012-07-25 Evonik Degussa Corporation Nach freisetzungsprofil unterschiedliche implantatvorrichtungen sowie verfahren zu ihrer herstellung und verwendung
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
WO1991011176A1 (en) * 1990-01-30 1991-08-08 Akzo N.V. Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
ZA935569B (en) * 1992-07-31 1994-04-12 Daratech Pty Ltd Controlled release implants
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
DE69734168T2 (de) * 1996-02-02 2006-01-19 Alza Corp., Mountain View Implantierbares System mit verzögerter Wirkstofffreisetzung

Also Published As

Publication number Publication date
NO995908D0 (no) 1999-12-02
EP1001743A1 (de) 2000-05-24
NO995908L (no) 1999-12-02
AU8109398A (en) 1998-12-21
EP1001743B1 (de) 2006-02-01
ATE316779T1 (de) 2006-02-15
JP2002511075A (ja) 2002-04-09
US6319512B1 (en) 2001-11-20
IL133105A0 (en) 2001-03-19
IL133105A (en) 2004-09-27
WO1998055101A1 (fr) 1998-12-10
AU742372B2 (en) 2002-01-03
CA2291659A1 (fr) 1998-12-10

Similar Documents

Publication Publication Date Title
DE69833375D1 (de) Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
AU1369297A (en) Medical implant
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
DE69520036T2 (de) Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen
NO178136C (no) Framgangsmåte for framstilling av et preparat for styrt frigjöring av en farmasöytisk aktiv substans
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
DE59709515D1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
UA26204C2 (uk) Спосіб запобігаhhя деградації кісткового протеза
ATE208200T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
DE68903059T2 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
AU8166191A (en) Method for treatment of bone wasting diseases
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69410042T2 (de) Esterverbindung, Wirkstoff zur Kontrolle von schädlichen Parasiten diese enthaltend als Wirksubstanz, Zwischenverbindung zur Herstellung der Esterverbindung, sowie Verfahren zur Herstellung der Zwischenverbindung
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique
WO2001095916A3 (de) Anticholestatisches arzneimittel

Legal Events

Date Code Title Description
8332 No legal effect for de